FBIOP
Fortress Biotech, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C-
Company Profile
CEO
Lindsay Allan Rosenwald
IPO Date
2017-11-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Fortress Biotech, Inc.
CEO
Lindsay Allan Rosenwald
IPO Date
2017-11-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US